Home LiteratureArticle Details
PMID: 11179339 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Interleukin-12- and gamma interferon-dependent protection against malaria conferred by CpG oligodeoxynucleotide in mice.

Infection and immunity ·Vol. 69 ·No. 3 ·2001-03-00 ·Pages 1643-9

Gramzinski RA, Doolan DL, Sedegah M, Davis HL, Krieg AM, Hoffman SL

Abstract

Unmethylated CpG dinucleotides in bacterial DNA or synthetic oligodeoxynucleotides (ODNs) cause B-cell proliferation and immunoglobulin secretion, monocyte cytokine secretion, and activation of natural killer (NK) cell lytic activity and gamma interferon (IFN-gamma) secretion in vivo and in vitro. The potent Th1-like immune activation by CpG ODNs suggests a possible utility for enhancing innate immunity against infectious pathogens. We therefore investigated whether the innate immune response could protect against malaria. Treatment of mice with CpG ODN 1826 (TCCATGACGTTCCTGACGTT, with the CpG dinucleotides underlined) or 1585 (ggGGTCAACGTTGAgggggG, with g representing diester linkages and phosphorothioate linkages being to the right of lowercase letters) in the absence of antigen 1 to 2 days prior to challenge with Plasmodium yoelii sporozoites conferred sterile protection against infection. A higher level of protection was consistently induced by CpG ODN 1826 compared with CpG ODN 1585. The protective effects of both CpG ODNs were dependent on interleukin-12, as well as IFN-gamma. Moreover, CD8+ T cells (but not CD4+ T cells), NK cells, and nitric oxide were implicated in the CpG ODN 1585-induced protection. These data establish that the protective mechanism induced by administration of CpG ODN 1585 in the absence of parasite antigen is similar in nature to the mechanism induced by immunization with radiation-attenuated P. yoelii sporozoites or with plasmid DNA encoding preerythrocytic-stage P. yoelii antigens. We were unable to confirm whether CD8+ T cells, NK cells, or nitric oxide were required for the CpG ODN 1826-induced protection, but this may reflect differences in the potency of the ODNs rather than a real difference in the mechanism of action of the two ODNs. This is the first report that stimulation of the innate immune system by CpG immunostimulatory motifs can confer sterile protection against malaria.

MeSH Terms
Adjuvants, Immunologic/therapeutic use Animals CD4-Positive T-Lymphocytes/immunology CD8-Positive T-Lymphocytes/immunology DNA/therapeutic use Dose-Response Relationship, Drug Interferon-gamma/immunology Interleukin-12/immunology Killer Cells, Natural Malaria/prevention & control Nitric Oxide/immunology Oligodeoxyribonucleotides Plasmodium yoelii Thionucleotides/therapeutic use
Chemicals
Adjuvants, Immunologic CpG ODN 1585 CpG ODN 1826 Oligodeoxyribonucleotides Thionucleotides Interleukin-12 Nitric Oxide Interferon-gamma DNA
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Gramzinski R A
Malaria Program, Naval Medical Research Center, Silver Spring, Maryland 20910-7500, USA.
Doolan D L
Sedegah M
Davis H L
Krieg A M
Hoffman S L
References (37)
37 references, click to expand
  1. Bacterial DNA induces NK cells to produce IFN-gamma in vivo and increases the toxicity of lipopolysaccharides.
    J Immunol. 1996 Jun 15;156(12):4570-5 PMID: 8648098
  2. Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity.
    J Exp Med. 1996 Apr 1;183(4):1739-46 PMID: 8666931
  3. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA.
    J Immunol. 1996 Sep 1;157(5):1840-5 PMID: 8757300
  4. Functional diversity of helper T lymphocytes.
    Nature. 1996 Oct 31;383(6603):787-93 PMID: 8893001
  5. Rapid immune activation by CpG motifs in bacterial DNA. Systemic induction of IL-6 transcription through an antioxidant-sensitive pathway.
    J Immunol. 1996 Dec 15;157(12):5394-402 PMID: 8955187
  6. Sterile protection of monkeys against malaria after administration of interleukin-12.
    Nat Med. 1997 Jan;3(1):80-3 PMID: 8986746
  7. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants.
    Nat Med. 1997 Aug;3(8):849-54 PMID: 9256274
  8. CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants.
    Eur J Immunol. 1997 Sep;27(9):2340-4 PMID: 9341778
  9. Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization.
    Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10833-7 PMID: 9380720
  10. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity.
    J Exp Med. 1997 Nov 17;186(10):1623-31 PMID: 9362523
  11. The World Health Report 1997--conquering suffering, enriching humanity.
    World Health Forum. 1997;18(3-4):248-60 PMID: 9478137
  12. Cytokines induce the development of functionally heterogeneous T helper cell subsets.
    Immunity. 1998 Mar;8(3):275-83 PMID: 9529145
  13. DNA as an adjuvant: capacity of insect DNA and synthetic oligodeoxynucleotides to augment T cell responses to specific antigen.
    J Exp Med. 1998 Apr 6;187(7):1145-50 PMID: 9529331
  14. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen.
    J Immunol. 1998 Jan 15;160(2):870-6 PMID: 9551923
  15. CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis.
    J Immunol. 1998 Apr 15;160(8):3627-30 PMID: 9558060
  16. Research toward vaccines against malaria.
    Nat Med. 1998 May;4(5 Suppl):520-4 PMID: 9585203
  17. CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge.
    J Immunol. 1998 Sep 1;161(5):2428-34 PMID: 9725240
  18. Gamma interferon production is critical for protective immunity to infection with blood-stage Plasmodium berghei XAT but neither NO production nor NK cell activation is critical.
    Infect Immun. 1999 May;67(5):2349-56 PMID: 10225894
  19. IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii model.
    J Immunol. 1999 Jul 15;163(2):884-92 PMID: 10395683
  20. Synthetic oligodeoxynucleotides containing CpG motifs enhance immunogenicity of a peptide malaria vaccine in Aotus monkeys.
    Vaccine. 1999 Aug 6;17(23-24):3065-71 PMID: 10462241
  21. Liver CD4-CD8- NK1.1+ TCR alpha beta intermediate cells increase during experimental malaria infection and are able to exhibit inhibitory activity against the parasite liver stage in vitro.
    J Immunol. 2000 Feb 1;164(3):1463-9 PMID: 10640763
  22. The role of CpG motifs in innate immunity.
    Curr Opin Immunol. 2000 Feb;12(1):35-43 PMID: 10679406
  23. Mechanism of action of CpG DNA.
    Curr Top Microbiol Immunol. 2000;247:1-21 PMID: 10689776
  24. CpG DNA as a Th1 trigger.
    Int Arch Allergy Immunol. 2000 Feb;121(2):87-97 PMID: 10705218
  25. Mechanisms and applications of immune stimulatory CpG oligodeoxynucleotides.
    Biochim Biophys Acta. 1999 Dec 10;1489(1):107-16 PMID: 10807001
  26. alpha -galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria.
    Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8461-6 PMID: 10900007
  27. Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity.
    J Natl Cancer Inst. 1984 Apr;72(4):955-62 PMID: 6200641
  28. Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon.
    Science. 1986 May 16;232(4752):881-4 PMID: 3085218
  29. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies.
    J Exp Med. 1987 Nov 1;166(5):1229-44 PMID: 2960769
  30. IFN-gamma inhibits development of Plasmodium berghei exoerythrocytic stages in hepatocytes by an L-arginine-dependent effector mechanism.
    J Immunol. 1991 Jun 1;146(11):3971-6 PMID: 1903415
  31. Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA.
    J Immunol. 1991 Sep 15;147(6):1759-64 PMID: 1890302
  32. Nitric oxide-mediated antiplasmodial activity in human and murine hepatocytes induced by gamma interferon and the parasite itself: enhancement by exogenous tetrahydrobiopterin.
    Infect Immun. 1994 Sep;62(9):4043-6 PMID: 8063424
  33. Interleukin 12 induction of interferon gamma-dependent protection against malaria.
    Proc Natl Acad Sci U S A. 1994 Oct 25;91(22):10700-2 PMID: 7938013
  34. CpG motifs in bacterial DNA trigger direct B-cell activation.
    Nature. 1995 Apr 6;374(6522):546-9 PMID: 7700380
  35. Interleukin-12 is required for interferon-gamma production and lethality in lipopolysaccharide-induced shock in mice.
    Eur J Immunol. 1995 Mar;25(3):672-6 PMID: 7705395
  36. The instructive role of innate immunity in the acquired immune response.
    Science. 1996 Apr 5;272(5258):50-3 PMID: 8600536
  37. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma.
    Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):2879-83 PMID: 8610135
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
2001-03-00
Pages
1643-9
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC98068
Subset
IM
Corrections
ErratumIn
-
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com